Medicenna Therapeutics Corp. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.06
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.07
|
-0.04
|
0.03
|
42.86%
|
|
2022-06-30
|
-0.08
|
-0.07
|
0.01
|
12.50%
|
|
2022-03-31
|
-0.11
|
-0.06
|
0.05
|
45.45%
|
|
2021-12-31
|
-0.13
|
-0.09
|
0.04
|
30.77%
|
|
2021-09-30
|
-0.12
|
-0.15
|
-0.03
|
-25.00%
|
|
2021-06-30
|
-0.10
|
-0.12
|
-0.02
|
-20.00%
|
|
2021-03-31
|
-0.09
|
-0.11
|
-0.02
|
-22.22%
|
|
2020-12-31
|
-0.08
|
-0.09
|
-0.01
|
-8.51%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.11
|
|
2022-03-31
|
-0.42
|
|
2021-03-31
|
-0.30
|
|
2020-03-31
|
-0.24
|
|
2019-03-31
|
-0.14
|
|
2018-03-31
|
-0.27
|